Pediatric Ilioinguinal / Iliohyogogastric Nerve Block

Ketamine

Brief Summary

Ilioinguinal / iliohyogogastric nerve blocks; It is frequently used for analgesia and anesthesia in inguinal region surgeons. However, 95% of these surgeons are under general anesthesia. aim of this study; Intra-operative anesthesia and analgesia effects of ilioinguinal / iliohyogogastric nerve block supported by ketamine sedation only.

Intervention / Treatment

  • Ketamine (DRUG)
    N/A

Condition or Disease

  • Intra-operative Anesthesia and Analgesia Effects

Phase

  • Not Applicable

    • Study Design

    Study type: INTERVENTIONAL
    Status: Unknown status
    Study results: No Results Available
    Age: 2 Years to 6 Years
    Enrollment: 60 (ESTIMATED)
    Funded by: Other
    Allocation: Randomized
    Primary Purpose: Supportive Care

    Masking

    DOUBLE:
    • Participant
    • Investigator

    Clinical Trial Dates

    Start date: Dec 01, 2016
    Primary Completion: Jul 01, 2017 ESTIMATED
    Completion Date: Sep 01, 2017 ESTIMATED
    Study First Posted: Dec 13, 2016 ESTIMATED
    Results First Posted: Aug 31, 2020
    Last Updated: Dec 08, 2016

    Sponsors / Collaborators

    Lead Sponsor: Erzincan University
    Responsible Party: N/A

    Participant Groups

    • Ilioinguinal / iliohypogastric block after ketamine atropine induction and continued with ketamine only in anesthesia

    • After ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane MAC and oxygen / air mixture and applied Ilioinguinal / iliohypogastric block.

    • After ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane MAC and oxygen / air mixture and Non-block, postoperative analgesia with paracetamol IV

    Eligibility Criteria

    Sex: All
    Minimum Age: 2
    Maximum Age: 6
    Age Groups: Child
    Healthy Volunteers: Yes

    Inclusion Criteria:

    * ASA I-II
    * To undergo elective lower abdominal surgery
    * between 2-6 years old

    Exclusion Criteria:

    * Patients with psychiatric disease
    * Patients whose weight is more than 40 kg
    * Patients with cardiac-pulmonary-neurological disease
    * Patients with bleeding disorder
    * Patients with infection or scar on the injection area
    * Patients with known allergies to local anesthetics

    Primary Outcomes
    • the amount of anesthetic drug which was used nine month
    Secondary Outcomes
    • Postoperative visual analogue scale nine month

    More Details

    NCT Number: NCT02990884
    Other IDs: ERZINCAN UNIVERSITY 6
    Study URL: https://clinicaltrials.gov/study/NCT02990884
    Last updated: Sep 29, 2023